is a rheumatologist/internist with 16 years of
clinical rheumatology experience.

For the last 10 years in addition to
his clinical practice he has been advising Pharmaceutical industry in
the development of new treatments for rheumatoid arthritis,
osteoarthritis, lupus, as well as other diseases.

He has been involved in the development and approval of 6 approved treatments for RA and SLE.